Skip to content
OpenCapital
Get started

Capital Bancorp CBNK Restricted Marketable Securities

Restricted Marketable Securities at other companies

QCR Holdings logo
QCR HoldingsQCRH
$24.29M-17.1%
Valley National Bank logo
Valley National BankVLY
$1.1B+21.9%
Enterprise Financial Services logo
Enterprise Financial ServicesEFSC
——

Other financials

Income statement

See full
Revenue$62.8M+7.1%
Operating income-$923.0K+8.4%
Net income$12.0M-13.7%
EPS (diluted)$0.73-11.0%

Balance sheet

See full
Cash & equivalents$399.3M+35.8%
Total debt$7.6M+38.0%
Total equity$408.9M+10.6%
Total assets$3.8B+13.7%

Cash flow

See full
Operating cash flow$21.8M-3.6%
CapEx$643.0K+231%
Free cash flow$21.1M-5.6%

Valuation

See full
Market cap$563.89M+8.2%
Enterprise value$172.15M-26.0%
P/E10.2×-3.4×
P/S2.3×-0.3×

Profitability

See full
Operating margin-1.6%-0.4pp
Net margin22.2%+3.3pp
FCF margin28.4%-0.5pp

Returns & leverage

See full
Return on equity14.2%+2.0pp
Debt / equity0×0.0×

Where this comes from

Reported directly by Capital Bancorp in its filing.

Tagged under the XBRL concept us-gaap:RestrictedInvestments.

The official record: Capital Bancorp’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capital Bancorp's restricted marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capital Bancorp's restricted marketable securities?
Capital Bancorp (CBNK) reported restricted marketable securities of $8.69M in Q1 2026.
How has Capital Bancorp's restricted marketable securities changed year-over-year?
Capital Bancorp's restricted marketable securities increased by 23.6% year-over-year, from $7.03M to $8.69M.
What is the long-term trend for Capital Bancorp's restricted marketable securities?
Over 5 years (2020 to 2025), Capital Bancorp's restricted marketable securities has grown at a 17.7% compound annual growth rate (CAGR), from $3.71M to $8.4M.
What does restricted marketable securities mean?
These are investment-grade financial instruments that are pledged as collateral or otherwise legally restricted from being sold or traded freely. They typically support specific operational requirements, such as securing public deposits or meeting regulatory pledging mandates. Their presence indicates a portion of the investment portfolio is committed to specific obligations rather than general liquidity.